siliconlabel
amino
acid
suitabl
latestag
fluorin
unexpect
oxid
cleavag
reaction
prepar
key
intermedi
strecker
synthesi
develop
clinic
use
peptidebas
vaccin
remain
longstand
goal
review
highlight
intrins
disord
protein
antigen
lack
order
threedimension
structur
repres
excel
start
point
develop
vaccin
disord
protein
repres
import
class
antigen
wide
rang
human
pathogen
contrari
widespread
belief
frequent
target
protect
antibodi
respons
importantli
disord
epitop
appear
invari
linear
epitop
render
ideal
suit
incorpor
peptid
vaccin
nonetheless
conform
properti
disord
antigen
henc
recognit
antibodi
frequent
depend
interact
make
context
present
immun
system
effect
must
consid
design
effect
vaccin
discuss
issu
propos
design
principl
may
facilit
develop
peptid
vaccin
target
disord
antigen
design
intrins
disord
antigen
malaria
membran
interact
peptid
epitop
structur
vaccin
indispens
tool
fight
diseas
signific
impact
public
health
sever
decad
tradit
vaccin
reli
use
liveattenu
inactiv
form
pathogen
induc
protect
immun
respons
howev
case
malaria
pathogen
difficult
cultur
vitro
larg
scale
moreov
use
whole
organ
vaccin
introduc
high
antigen
load
often
small
subset
antigen
drive
protect
also
possibl
advers
allergen
reaction
certain
antigen
prepar
obstacl
led
increas
interest
subunit
vaccin
singl
select
protein
use
vaccin
formul
induc
protect
immun
use
peptid
vaccin
take
rational
even
singl
protein
antigen
may
mani
epitop
contribut
protect
immun
peptid
vaccin
offer
mean
formul
vaccin
contain
epitop
capabl
induc
posit
effici
immun
respons
eas
peptid
synthesi
make
larg
scale
product
feasibl
whilst
also
offer
cleaner
vaccin
prepar
lack
biolog
contamin
commonli
associ
recombin
express
whole
organ
vaccin
specif
peptid
also
allow
improv
customis
facilit
exampl
multiepitop
approach
target
differ
strain
stage
life
cycl
pathogen
reason
longstand
interest
area
vaccin
design
peptid
vaccin
reach
clinic
trial
target
wide
rang
indic
tabl
seven
vaccin
reach
phase
iii
trial
tabl
much
recent
interest
focuss
tcell
epitop
vaccin
reach
phase
iii
tcell
base
mani
diseas
howev
bcell
respons
also
play
import
role
immun
protect
peptidebas
vaccin
base
bcell
epitop
prove
challeng
number
reason
owe
small
size
peptid
gener
poorli
immunogen
addit
tcell
epitop
requir
establish
robust
immun
respons
may
also
absent
smaller
peptid
address
issu
carrier
protein
adjuv
typic
includ
vaccin
formul
peptid
also
prone
enzymat
degrad
combat
epitop
modifi
conform
stabil
cyclis
peptid
mimet
resist
proteolysi
use
final
perhap
importantli
peptidebas
approach
limit
antibodi
respons
mani
protein
antigen
domin
conform
epitop
difficult
imposs
captur
effect
peptidebas
design
review
argu
intrins
disord
protein
antigen
lack
order
threedimension
structur
repres
excel
start
point
develop
peptid
vaccin
argument
structur
follow
first
establish
disord
protein
repres
import
class
antigen
wide
rang
human
pathogen
second
describ
uniqu
featur
antigen
interact
antibodi
highlight
properti
render
particularli
suit
develop
peptid
vaccin
particular
note
disord
epitop
appear
invari
linear
epitop
challeng
captur
conform
epitop
peptid
vaccin
may
appli
outlin
opportun
challeng
present
peptidebas
approach
vaccin
develop
exemplifi
effort
develop
vaccin
base
disord
malaria
antigen
final
specul
futur
develop
within
peptid
scienc
beyond
fulli
enabl
promis
approach
realiz
intrins
disord
protein
found
throughout
biolog
particularli
enrich
context
molecular
signal
regulatori
function
consist
regulatori
role
extent
disord
within
proteom
individu
speci
tend
increas
environment
complex
organ
lifecycl
thu
organ
live
divers
highli
variabl
environ
tend
highli
disord
proteom
reflect
need
sophist
regulatori
mechan
surviv
environment
divers
result
disord
protein
particularli
abund
rang
pathogen
organ
virus
must
surviv
divers
often
hostil
host
environ
context
disord
protein
play
import
role
hostpathogen
interact
accordingli
disord
protein
often
expos
host
immun
system
even
amongst
bacteria
significantli
order
proteom
eukaryot
speci
mani
protein
involv
pathogen
effector
mechan
appear
disord
often
assum
disord
antigen
imped
develop
effect
immun
respons
henc
abund
repres
adapt
mechan
enabl
pathogen
evad
immun
respons
mechan
propos
account
immun
evas
divers
contest
critic
assess
sever
mechan
section
despit
fact
hypothes
receiv
limit
direct
experiment
support
underli
assumpt
repetit
disord
antigen
fail
elicit
effect
antibodi
respons
continu
enjoy
signific
currenc
howev
recent
sequenc
genom
sever
speci
parasit
demonstr
lowcomplex
disord
sequenc
unusu
abund
wide
rang
gene
includ
mani
appear
antigen
import
suggest
presenc
sequenc
parasit
primarili
strategi
evad
host
immun
respons
prompt
signific
debat
surround
mechan
respons
gener
maintain
abund
lowcomplex
sequenc
fact
seem
like
distinct
class
lowcomplex
sequenc
exist
within
parasit
genom
suggest
divers
contributori
mechan
disord
antigen
import
target
vaccin
develop
note
abund
disord
lowcomplex
sequenc
plasmodium
speci
respons
malaria
relat
parasit
first
identifi
analysi
antigen
import
protein
surpris
substanti
fraction
malaria
vaccin
candid
contain
region
disord
region
often
import
target
antibodi
promin
exampl
circumsporozoit
protein
csp
domin
antigen
surfac
sporozoit
parasit
form
inject
host
mosquito
must
replic
within
host
hepatocyt
prior
establish
symptomat
bloodstag
infect
csp
extens
studi
antigen
inclus
malaria
vaccin
recentlyapprov
vaccin
rt
includ
ctermin
half
csp
fuse
hepat
b
santigen
assembl
viruslik
particl
rt
antigen
includ
thrombospondin
repeat
domain
cterminu
csp
although
clear
domain
correctli
fold
vaccin
formul
rest
csp
predict
disord
predict
confirm
experiment
tetrapeptid
repeat
csp
appear
immunodomin
target
protect
antibodi
induc
rt
second
import
malaria
vaccin
candid
entir
disord
merozoit
surfac
protein
antibodi
target
aris
cours
malaria
infect
presenc
antibodi
correl
protect
subsequ
infect
also
induc
robust
antibodi
respons
use
vaccin
respons
shown
mediat
protect
phase
iib
trial
papua
new
guinea
conform
antigen
properti
subject
extens
studi
provid
import
insight
interplay
antigen
disord
return
section
mani
addit
antigen
signific
interest
vaccin
candid
malaria
diseas
known
predict
disord
highlight
number
exampl
tabl
appar
howev
mani
case
disord
natur
antigen
wide
appreci
rais
possibl
mani
import
antigen
yet
recogn
disord
preced
discuss
establish
disord
protein
import
antigen
broad
rang
immunolog
context
would
natur
suppos
antibodi
abl
effect
recogn
disord
antigen
hand
also
allud
number
argument
suggest
antibodi
respons
disord
antigen
dysfunct
even
absent
address
appar
contradict
recent
assembl
larg
dataset
wellcharacter
protein
antigen
immun
epitop
databas
iedb
epitop
aris
protein
region
predict
disord
well
repres
dataset
fact
found
posit
correl
predict
disord
likelihood
put
epitop
test
posit
antibodi
bind
assay
report
iedb
establish
disord
impedi
effect
antibodi
recognit
figur
other
recent
made
observ
extend
show
predictor
protein
disord
outperform
dedic
sequencebas
predictor
identif
bcell
epitop
may
reflect
fact
residu
score
highli
disord
predictor
like
solventexpos
solvent
exposur
prerequisit
establish
predictor
antigen
affin
matur
antibodi
disord
antigen
argu
disord
antigen
may
imped
develop
effect
immun
respons
interf
process
bcell
matur
differenti
memori
antibodi
produc
cell
process
matur
antibodi
undergo
somat
hypermut
select
highaffin
antigen
bind
affin
matur
essenti
develop
highaffin
longliv
antibodi
respons
affin
matur
antibodi
disord
antigen
significantli
imped
would
expect
antibodi
fewer
mutat
respect
germlin
antibodi
sequenc
antibodi
order
antigen
fact
compar
avail
antibodi
sequenc
correspond
germlin
sequenc
detect
differ
number
vgene
mutat
two
class
antibodi
figur
impli
affin
matur
proce
equival
efficaci
antibodi
order
disord
antigen
highli
repetit
antigen
capabl
elicit
bcell
respons
independ
tcell
help
normal
requir
bcell
matur
respons
character
defect
affin
matur
failur
establish
convent
memori
respons
propos
one
reason
bcell
repetit
disord
antigen
may
fail
matur
inde
repetit
malaria
antigen
csp
induc
bcell
respons
absenc
tcell
help
respons
much
weaker
transient
presenc
tcell
thu
normal
respons
prototyp
repetit
antigen
tcell
depend
fig
ure
disord
antigen
bona
fide
target
antibodi
recognit
epitop
within
disord
protein
region
like
target
posit
antibodi
bind
assay
b
antibodi
disord
epitop
purpl
order
epitop
green
subject
similar
level
somat
hypermut
c
disord
account
small
fraction
variabl
antibodi
affin
disord
epitop
purpl
exclus
short
linear
epitop
order
epitop
green
predominantli
conform
epitop
span
mani
residu
primari
sequenc
modifi
permiss
ref
addit
specif
evid
affin
matur
antibodi
target
epitop
come
recent
studi
antibodi
respons
induc
clinic
trial
rt
vaccin
context
natur
infect
studi
basi
misconcept
disord
protein
poorli
recogn
antibodi
aris
fact
disord
epitop
definit
fail
adopt
singl
welldefin
conform
context
nativ
protein
might
recogn
antibodi
clear
howev
disord
protein
capabl
recogn
protein
bind
partner
antibodi
otherwis
achiev
disord
protein
often
undergo
process
coupl
fold
bind
bind
partner
act
effect
templat
disord
protein
fold
rel
welldefin
bound
conform
nonetheless
coupl
fold
bind
place
kinet
thermodynam
constraint
interact
particular
signific
entrop
cost
fold
reduc
overal
bind
affin
interact
unless
cost
offset
mean
thu
interact
disord
protein
often
rel
low
affin
despit
maintain
high
specif
properti
ideal
suit
mediat
signal
must
switch
rapidli
account
enrich
disord
protein
involv
signal
transduct
regul
interact
quit
distinct
howev
typic
antibodyantigen
interact
select
high
affin
slow
dissoci
consider
rais
possibl
antibodi
recogn
disord
antigen
may
reduc
affin
reflect
substanti
entrop
cost
must
accompani
disord
antigen
adopt
singl
antibodybound
conform
fact
use
dataset
order
disord
epitop
iedb
shown
disord
account
littl
wide
variat
observ
affin
antibodi
protein
antigen
specif
observ
approxim
sevenfold
differ
median
affin
antibodi
recogn
order
epitop
recogn
disord
epitop
loss
affin
much
smaller
might
expect
basi
expect
entrop
cost
coupl
fold
bind
figur
investig
structur
basi
rel
high
affin
antibodi
recogn
disord
antigen
crossreferenc
iedbderiv
dataset
order
disord
antigen
protein
databank
pdb
result
set
structur
antibodyprotein
complex
repres
disord
epitop
comparison
structur
reveal
disord
epitop
involv
substanti
fewer
residu
order
epitop
perhap
mean
minim
entrop
cost
bind
figur
thu
disord
epitop
rare
span
residu
antigen
primari
sequenc
major
residu
make
direct
interact
antibodi
structur
observ
consist
epitop
map
experi
larg
number
antibodi
sever
disord
antigen
impli
disord
epitop
overwhelmingli
linear
epitop
antibodi
recognit
determin
larg
local
antigen
sequenc
stand
contrast
convent
order
antigen
larg
fraction
antibodi
respons
typic
direct
conform
epitop
implic
reduct
size
disord
epitop
disord
epitop
much
effici
order
epitop
interact
antibodi
sens
achiev
bind
free
energi
per
unit
interact
surfac
area
per
epitop
residu
comparison
structur
antibodybound
order
disord
antigen
reveal
number
featur
antibodyantigen
interact
may
contribut
effici
includ
concav
antigen
bind
site
better
complementar
shape
antigen
well
twofold
increas
number
intermolecular
hbond
per
epitop
residu
structur
featur
impli
antibodi
disord
epitop
better
match
bound
conform
epitop
antibodi
order
epitop
like
reflect
extent
abil
disord
epitop
adapt
bind
site
antibodi
inde
flexibl
permit
disord
epitop
adopt
distinct
conform
bound
differ
antibodi
nonetheless
exquisit
complementar
also
like
requir
adapt
part
antibodi
may
also
seen
evid
support
conclus
affin
matur
antibodi
disord
epitop
least
effect
affin
matur
target
order
epitop
place
preced
gener
consider
specif
foot
outlin
implic
context
vaccin
develop
effort
disord
malaria
antigen
highli
abund
ctermin
glycosylphosphatidylinositol
gpi
anchor
bloodstag
surfac
antigen
malaria
parasit
p
falciparum
potenti
compon
malaria
vaccin
conserv
nand
ctermin
region
flank
central
region
compris
polymorph
repetit
sequenc
nonrepetit
sequenc
predominantli
dimorph
figur
dimorph
sequenc
within
central
variabl
region
differenti
variant
two
allel
famili
combin
b
vaccin
includ
one
three
protein
antigen
yield
evid
protect
clinic
trial
papua
new
guinea
protect
strainspecif
vaccin
protect
malari
strain
express
sequenc
thu
primari
concern
vaccin
develop
like
mani
malaria
antigen
address
polymorph
antigen
although
studi
describ
establish
disord
impedi
develop
robust
antibodi
respons
interplay
disord
antigen
may
complic
level
singl
antigen
studi
compar
experiment
measur
conform
disord
deriv
nmr
relax
rate
observ
pattern
antigen
infer
experiment
immun
anim
human
result
studi
contrast
bioinformat
analysi
key
advantag
afford
peptidebas
approach
vaccin
develop
abil
omit
ineffect
region
polymorph
region
entir
ensur
respons
focus
conserv
epitop
like
elicit
broadli
protect
respons
exemplifi
long
synthet
peptid
deriv
ctermin
half
consid
potenti
compon
malaria
vaccin
peptid
includ
conserv
dimorph
familyspecif
sequenc
exclud
highli
polymorph
region
beyond
specif
immedi
epitopeantibodi
interact
broader
context
antibodi
encount
antigen
like
influenc
way
antibodi
abl
recogn
disord
antigen
effect
wellknown
case
order
antigen
aris
exampl
molecular
interact
lead
conform
chang
mask
disrupt
epitop
otherwis
render
cryptic
similar
effect
like
disord
antigen
inde
conform
properti
disord
protein
uniqu
sensit
modul
interact
posttransl
modif
mechan
antibodi
recognit
disord
epitop
may
expect
particularli
sensit
context
antibodi
recogn
exampl
seen
mask
conserv
epitop
amongst
panel
monoclon
mous
antibodi
rais
recombin
target
variabl
epitop
also
recogn
parasit
surfac
wherea
mani
antibodi
target
conserv
epitop
recogn
parasit
weakli
figur
togeth
data
impli
least
conserv
epitop
within
may
mask
conform
interact
adopt
antigen
parasit
surfac
structur
basi
mask
recent
character
case
one
epitop
murin
monoclon
antibodi
mab
recogn
epitop
conserv
ntermin
region
bind
recombin
epitopederiv
peptid
high
affin
yet
fail
recogn
parasit
surfac
ntermin
region
includ
epitop
bind
lipid
adopt
amphipath
helic
conform
expect
heavili
popul
parasit
given
gpianchor
parasit
membran
helic
conform
incompat
conform
recogn
reveal
xray
crystallographi
figur
b
moreov
epitop
lost
recombin
protein
ctermin
tether
lipid
vesicl
indic
ntermin
interact
lipid
accompani
conform
chang
suffici
account
observ
mask
epitop
parasit
surfac
explor
impact
lipid
conjug
ctermin
domain
shorter
construct
residu
consist
conserv
ctermin
region
gener
epitop
panel
monoclon
antibodi
also
shown
antibodi
strongli
recogn
parasit
antigen
blue
text
weakli
red
mani
residu
interact
lipid
includ
epitop
recogn
ctermin
region
specif
monoclon
antibodi
mab
contrast
ntermin
region
howev
indic
stabl
helic
conform
within
lipidbound
nonetheless
antigen
liposomeconjug
fulllength
alter
comparison
lipidfre
recombin
peptid
figur
importantli
also
appear
bind
pattern
ctermin
specif
mab
liposomeconjug
antigen
figur
consist
mab
parasit
lysat
thu
lipid
tether
appear
alter
antigen
state
construct
render
similar
antigen
parasit
surfac
lipidconjug
base
vaccin
may
therefor
provid
effect
antibodi
respons
similar
mask
potenti
protect
epitop
seen
preerythrocyt
malaria
antigen
csp
although
repetit
sequenc
csp
long
focu
vaccin
develop
effort
recent
studi
identifi
epitop
within
conserv
ntermin
region
appear
contribut
protect
respons
csp
context
natur
immun
vaccin
antibodi
act
synergist
antibodi
target
csp
repeat
cours
parasit
develop
within
mosquito
subsequ
migrat
human
host
liver
csp
undergo
proteolyt
process
essenti
establish
liverstag
infect
proteolysi
expos
otherwis
cryptic
epitop
nand
ctermin
region
csp
indic
conform
chang
appear
involv
longrang
interact
within
csp
turn
determin
access
ntermin
epitop
natur
interact
associ
conform
chang
remain
larg
obscur
light
efficaci
antibodi
target
ntermin
possibl
also
ctermin
epitop
like
better
understand
interact
facilit
design
improv
cspbase
vaccin
construct
disord
protein
typic
adopt
welldefin
structur
interact
bind
partner
describ
nonetheless
case
signific
disord
persist
interact
give
rise
known
fuzzi
interact
becom
increa
b
mabbound
pdb
id
key
paratop
residu
involv
bind
shown
white
ahel
configur
lipidbound
peptid
remov
backbon
flexibl
requir
access
provid
structur
rational
epitop
mask
parasit
membran
c
schemat
lipid
tether
ctermin
region
synthes
ctermin
tag
immobil
nickel
bound
nickelchel
lipid
elisa
show
effect
lipid
tether
bind
four
ctermin
regionspecif
mous
mab
five
fold
nmr
experi
provid
evid
transient
interact
resolv
crystal
structur
involv
variabl
residu
distal
structur
defin
epitop
transient
fuzzi
interact
thu
appear
modul
specif
render
antibodi
somewhat
strainspecif
spite
conserv
natur
epitop
although
gener
effect
remain
establish
appear
origin
larg
nonspecif
interact
occur
almost
inevit
result
high
effect
concentr
disord
region
immedi
flank
structur
defin
epitop
expect
similar
fuzzi
interact
may
contribut
antibodi
recognit
mani
disord
antigen
conserv
ctermin
region
particularli
immunodomin
total
five
mous
mab
abl
recogn
overlap
epitop
span
discuss
antibodi
target
conserv
region
shown
differ
abil
recogn
parasit
figur
upon
antibodi
bind
peptid
epitop
found
adopt
bbend
ribbon
conform
character
consecut
overlap
bturn
figur
two
bturn
epitop
stabil
hydrogen
bond
involv
allow
key
interact
residu
paratop
structur
inform
suggest
strategi
stabil
analogu
epitop
could
optim
use
peptid
vaccin
view
guid
specif
antibodi
respons
toward
epitop
conserv
access
parasit
surfac
thu
like
contribut
broadli
protect
immun
respons
disord
protein
highli
abund
infecti
organ
across
kingdom
life
protein
bona
fide
target
antibodi
respons
context
natur
infect
vaccin
contrast
widelyheld
view
disord
antigen
fail
elicit
effect
antibodi
respons
clear
play
import
role
protect
antigen
rang
diseas
tabl
epitop
disord
antigen
typic
short
linear
epitop
complex
conform
epitop
domin
order
antigen
disord
antigen
well
suit
target
peptid
vaccin
despit
potenti
promis
approach
care
consider
must
paid
context
target
epitop
recogn
immun
system
conform
antigen
properti
disord
antigen
strongli
modul
interact
nativ
parasit
context
vaccin
formul
mismatch
parasit
vaccin
context
probabl
contribut
failur
number
peptidebas
vaccin
strategi
use
long
peptid
vaccin
formul
potenti
incorpor
sever
protect
epitop
within
nativ
sequenc
may
offer
one
strategi
address
issu
potenti
effect
approach
defin
structur
disord
peptid
epitop
bound
cognat
antibodi
use
structur
inform
basi
design
peptid
structur
stabil
end
rang
avail
strategi
stabil
conform
synthet
peptid
repres
clear
advantag
peptid
vaccin
approach
futur
develop
area
enabl
stabil
wider
rang
peptid
conform
limit
perturb
residu
essenti
antibodi
bind
serv
broaden
scope
strategi
clear
target
vaccin
develop
strategi
describ
requir
detail
understand
function
determin
immun
protect
specif
antigen
epitop
respons
mediat
function
well
understood
pathogen
less
studi
immunolog
complex
pathogen
inform
may
still
emerg
context
new
strategi
highthroughput
profil
immunolog
respons
identif
correl
immun
protect
repres
welcom
advanc
promis
allow
peptidebas
vaccin
develop
diseas
effect
vaccin
current
exist
